Calamos Advisors’s Organon & Co OGN Stock Holding History

Calamos Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-51,781	Closed	-$899K	–	964
2023 Q3	$899K	Hold	51,781	–	–	﹤0.01%	680
2023 Q2	$1.08M	Hold	51,781	–	–	0.01%	698
2023 Q1	$1.22M	Sell	51,781 -6,474	-11%	-$174K	0.01%	783
2022 Q4	$1.63M	Sell	58,255 -10,299	-15%	-$263K	0.01%	819
2022 Q3	$1.6M	Sell	68,554 -4	-0%	-$121	0.01%	896
2022 Q2	$2.31M	Buy	68,558 +1,846	+3%	+$64.7K	0.01%	898
2022 Q1	$2.33M	Buy	66,712 +8,892	+15%	+$304K	0.01%	897
2021 Q4	$1.76M	Buy	57,820 +2,238	+4%	+$72.9K	0.01%	921
2021 Q3	$1.82M	Buy	55,582 +4,904	+10%	+$157K	0.01%	791
2021 Q2	$1.53M	Buy	+50,678	New	+$1.67M	0.01%	759

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Calamos Advisors's OGN Position: Q4 2023 in Review

Calamos Advisors sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 51,781 shares — an estimated $899K sold.

Calamos Advisors first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $2.33M in Q1 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Calamos Advisors reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Calamos Advisors sold 51,781 Organon & Co shares in Q4 2023, an estimated $899K.
Calamos Advisors first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
Calamos Advisors's Organon & Co position peaked at $2.33M in Q1 2022.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Calamos Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.